Coronavirus: Remdesivir has ‘little effect’ on death risks, says WHO

15 octobre 2020 Non Par ADMIN

According to an article published on the website dailymail.co.uk on 15 octobre 2020 by ,

The WHO’s 11,266-person trial found no significant reduction in mortality risks among hospitalized COVID-19 patients treated with remdesivir, lopinavir, interferon or hydroxychloroquine

Go to Source